{"id":"https://openalex.org/W2003708984","doi":null,"title":"Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","display_name":"Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","publication_year":1996,"publication_date":"1996-08-28","ids":{"openalex":"https://openalex.org/W2003708984","mag":"2003708984"},"language":"en","primary_location":{"id":"mag:2003708984","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA28934014","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"book","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015501263","display_name":"Stephen M. Stahl","orcid":"https://orcid.org/0000-0002-6536-6973","observed_orcids":["https://orcid.org/0000-0002-6536-6973"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen M. Stahl","raw_affiliation_strings":["U California, San Diego, CA, US"],"raw_orcid":"https://orcid.org/0000-0002-6536-6973","affiliations":[{"raw_affiliation_string":"U California, San Diego, CA, US","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015501263"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":null,"apc_paid":null,"fwci":1.5433,"has_fulltext":false,"cited_by_count":363,"citation_normalized_percentile":{"value":0.84337349,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.475600004196167,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.475600004196167,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.32690000534057617,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.16019999980926514,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psychopharmacology","display_name":"psychopharmacology","score":0.9879999756813049},{"id":"https://openalex.org/keywords/neurotransmission","display_name":"neurotransmission","score":0.9440000057220459},{"id":"https://openalex.org/keywords/neurotransmitter-receptors","display_name":"neurotransmitter receptors","score":0.7710000276565552},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8119999766349792},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9629999995231628},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9950000047683716},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/noradrenergic-reuptake-inhibitors","display_name":"noradrenergic reuptake inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/mood-stabilizers","display_name":"mood stabilizers","score":0.9710000157356262},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.9580000042915344},{"id":"https://openalex.org/keywords/sedative-hypnotics","display_name":"sedative-hypnotic drugs","score":0.9739999771118164},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.953000009059906},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.9890000224113464},{"id":"https://openalex.org/keywords/phobic-disorders","display_name":"phobia","score":0.9710000157356262},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.925000011920929},{"id":"https://openalex.org/keywords/nootropics","display_name":"nootropic drugs","score":0.9950000047683716},{"id":"https://openalex.org/keywords/reward","display_name":"reward","score":0.8709999918937683},{"id":"https://openalex.org/keywords/drugs-of-abuse","display_name":"drugs of abuse","score":0.906000018119812},{"id":"https://openalex.org/keywords/gender-differences-in-drug-response","display_name":"gender differences in drug response","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C103709681","wikidata":"https://www.wikidata.org/wiki/Q1515727","display_name":"Psychopharmacology","level":2,"score":0.7903302907943726},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5630896091461182},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.5092171430587769},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.47641170024871826},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4647212624549866},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.4606836140155792},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.45456036925315857},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.43554559350013733},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4187447428703308},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3549014925956726},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32994240522384644},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.31688326597213745},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2410363256931305}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2003708984","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/ncid/BA28934014","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2972479659","https://openalex.org/W560409725","https://openalex.org/W594392717","https://openalex.org/W8598180","https://openalex.org/W643597415","https://openalex.org/W4320160210","https://openalex.org/W7094945742","https://openalex.org/W4366525744","https://openalex.org/W1521146723","https://openalex.org/W3198380717"],"abstract_inverted_index":{"Preface":[0],"1.":[1],"Principles":[2],"of":[3,13,19,27,80,84],"chemical":[4],"neurotransmission":[5,23],"2.":[6],"Receptors":[7],"and":[8,32,42,49,54,65,70,82,88],"enzymes":[9],"as":[10,24],"the":[11,25],"targets":[12],"drug":[14],"action":[15],"3.":[16],"Special":[17],"properties":[18],"receptors":[20],"4.":[21],"Chemical":[22],"mediator":[26],"disease":[28],"actions":[29],"5.":[30],"Depression":[31],"bipolar":[33],"disorders":[34,67],"6.":[35],"Classical":[36],"antidepressants,":[37],"serotonin":[38],"selective":[39],"reuptake":[40,44],"inhibitors":[41,45],"noradrenergic":[43],"7.":[46],"Newer":[47],"antidepressants":[48],"mood":[50],"stabilizers":[51],"8.":[52],"Anxiolytics":[53],"sedative-hypnotics":[55],"9.":[56],"Drug":[57],"treatments":[58],"for":[59],"obsessive":[60],"compulsive":[61],"disorder,":[62],"panic":[63],"disorder":[64],"phobic":[66],"10.":[68],"Psychosis":[69],"schizophrenia":[71],"11.":[72],"Antipsychotic":[73],"agents":[74],"12.":[75],"Cognitive":[76],"enhancers":[77],"13.":[78],"Psychopharmacology":[79],"reward":[81],"drugs":[83],"abuse":[85],"14.":[86],"Gender":[87],"sexual":[89],"psychopharmacology":[90],"References":[91],"Index.":[92]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}